Reply to “Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer:  Both Are Essential to Maximize Survival Benefit”

2017-04-01

Annals of Surgery , Volume 265 - Issue 4 p. e42- e43

Additional Metadata
Persistent URL	doi.org/10.1097/SLA.0000000000001197, hdl.handle.net/1765/84324
Journal	Annals of Surgery
Organisation	Department of Surgery
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Talsma, A., Wijnhoven, B., Steyerberg, E., & van Lanschot, J. (2017). Reply to “Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit”. Annals of Surgery, 265(4), e42–e43. doi:10.1097/SLA.0000000000001197

Publication